Wearable Injectors Market Size, Share, Growth Report 2030

The report covers a forecast and an analysis of the wearable injectors market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the wearable injectors market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the wearable injectors market on a global and regional level.

In order to give the users of this report a comprehensive view of the wearable injectors market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the wearable injectors market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the wearable injectors market on a global and regional basis. 

Request Free Sample

The study provides a decisive view of the wearable injectors market based on type, therapeutic application, end-user, and region. By type, the market is segmented into off-body injectors and on-body injectors. By therapeutic application, the market is segmented into cardiovascular diseases, diabetes, immuno-oncology, and others. Home care settings, clinics, hospitals, and others form the end-user segment of the wearable injectors market.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global wearable injectors market include Medtronic PLC, Amgen, Ypsomed, Tandem Diabetes Care, Inc., Insulet Corporation, Becton, Dickinson, and Company, Valeritas, Inc., United Therapeutics Corporation, SteadyMed Therapeutics, Enable Injections, and Sensile Medical.

This report segments the global wearable injectors market as follows:

Global Wearable Injectors Market: By Type

• On-Body Injectors
• Off-Body Injectors

Global Wearable Injectors Market: By Application

• Immuno-Oncology
• Diabetes
• Cardiovascular Diseases
• Others

Global Wearable Injectors Market: By End-User

• Hospitals
• Clinics
• Home Care Settings
• Others

Global Wearable Injectors Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa